Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational ...

This was the stock's second consecutive day of losses.

Shares of Bio-Techne Corp. slid 5.79% to $46.66 Wednesday, on what proved to be an all-around poor trading session for the ...

HyClone Laboratories, LLC (“HyClone”) filed a Motion to Quash in the U.S. District Court for the District of Utah, seeking to ...

RBC Capital Markets Global Healthcare Conference May 21, 2025 9:00 AM ETCompany ParticipantsJustin Claeys - VP, IRKave Niksefat ...

Viridian Therapeutics’ veligrotug has shown one-year durability in a Phase III trial in patients with active thyroid eye ...

Prodigy Asset Management invested $268,000 in Amgen by acquiring 1,028 shares, giving the biotech giant a modest 0.2% slice ...

Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses the company's nationwide push to reduce cardiovascular risk ...

On May 15, 2025, a jury returned a verdict finding Amgen Inc. (“Amgen”) liable for antitrust violations and awarding Regeneron Pharmaceuticals, ...

Nissay Asset Management Corp Japan ADV boosted its Amgen stake by acquiring 6,489 more shares in Q4, joining a stampede of ...

Given a list of 40 drugmakers, the respondents rated ViiV most highly in terms of corporate reputation, followed by ...